Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024

Core Viewpoint - Agile Therapeutics, Inc. is set to report its fourth quarter and full year 2023 financial results on March 28, 2024, followed by a conference call to discuss these results and provide a business update [1]. Group 1: Financial Results Announcement - The company will announce its financial results before the market opens on March 28, 2024 [1]. - A live conference call and webcast will take place at 8:30 a.m. ET to discuss the financial results [1]. - The conference call can be accessed via the Investor Relations section of the Agile Therapeutics website [1]. Group 2: Company Overview - Agile Therapeutics is focused on women's healthcare, aiming to address unmet health needs [2]. - The company's product, Twirla®, is a non-daily prescription contraceptive based on proprietary transdermal patch technology called Skinfusion® [2]. - Twirla® provides women with contraceptive options that do not require daily intake, offering flexibility without long-term commitment [2].